1 result(s) for
|PI Name||Protocol #||Title|
|Zahi Mitri||STUDY00020440||A Modular, Multipart, Multiarm, Open-label, Phase I/IIa Study to Evaluate the Safety and Tolerability of CT7001 Alone and in Combination with Anti-cancer Treatments in Patients with Advanced Malignancies|
You may also qualify for Phase 1 Program trials.
For more information: